Feature Channels:

Blood Disorders

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Ethnicity & Disease, Lisa A. Cooper, Hypertension, heart diseaes, Cardiovascular, Blood Pressure, Racial, Lisa Cooper, Disparities

To Beat Hypertension, Take the 'Clinic' to the People

HiRes1.jpg

Eliminating racial disparities in the outcomes of programs to control blood pressure can be accomplished with a few one-on-one coaching sessions delivered by health professionals —but not if the program requires people to get to a clinic, according to results of a new Johns Hopkins Medicine study. The finding, described in the current issue of the Ethnicity & Disease journal, adds to mounting evidence that health and wellness programs work best when medical practitioners go out to people in their communities.

Medicine

Channels:

zika virus

Virginia Tech Epidemiology Expert Says New Zika Cases Will Help Researchers Predict U.S. Transmission

zikateam.png

Medicine

Channels:

clinical laboratory, AACC Annual Scientific Meeting, Healthcare

Ortho Clinical Diagnostics to Present Seven Scientific Posters, Six Products at AACC

Ortho Clinical Diagnostics will present seven scientific posters on its assays and display six products at the 2016 American Association for Clinical Chemistry (AACC) annual meeting. Ortho’s posters will address a range of important tests, both marketed and in-development for clinical labs.

Medicine

Channels:

Obesity, Metabolism, Hypertension, Renin Angiotensin System

Blood Pressure Hormone Promotes Obesity

GrobeJustin2.jpg

New research by University of Iowa scientists helps explain how a hormone system often targeted to treat cardiovascular disease can also lower metabolism and promote obesity.

Medicine

Channels:

Leukemia, Leukaemia, Cancer, Cancer Treatment, Drug Resistance

Early Detection of Leukemia Patients' Resistance to Therapy

laura-eadie.jpg

Australian researchers have made a world-first breakthrough in the early detection of patients' resistance to a common treatment for chronic myeloid leukemia.

Medicine

Channels:

Immunology/Allergies/Asthma, infectious and emerging disease, Medicine & Health, Public Health, Vaccine

'Screen-and-Treat' Scheme for Hepatitis B May Prevent Deadly Complications

Research into Africa's first 'screen-and-treat' programme for hepatitis B suggests the initiative may reduce deadly complications of the virus.

Medicine

Channels:

jonathan gutman, University Of Colorado Cancer Center, Graft Versus Host Disease, GvHD risk, Cord Blood, Bone Marrow Transplant, Leukemia

Cord Blood Outperforms Matched, Unrelated Donor in Bone Marrow Transplant

Gutman.MUD.v.CBT.png

A University of Colorado Cancer Center study finds that three years post bone marrow transplant, the incidence of severe chronic graft-versus-host disease was 44 percent in patients who had received transplants from matched, unrelated donors (MUD) and 8 percent in patients who had received umbilical cord blood transplants (CBT).

Medicine

Channels:

Researchers ID Cancer Gene-Drug Combinations Ripe for Precision Medicine; Many Skin Cancer Patients Still Too Likely to Sunburn; Researchers Block Common Type of Colon Cancer Tumor in Mice, and More in the Cancer News Source

Personalized Medicine Leads to Better Outcomes; Phase 1 Study Results of Selinexor Combination Therapy for Multiple Myeloma Patients; and the Latest from ASCO Sessions in the Cancer News Source

Medicine

Channels:

Ultrasound, training simulator

New Training Tool Allows Clinicians to Hone Vasculature Ultrasound Skills

UltrasoundSimulator.jpg

University of Washington researchers have developed the first simulator for duplex ultrasound scanning, a type of ultrasound used to assess the health of blood vessels.

Medicine

Channels:

Hematology, coagulation factor, FXa, FXa inhibitors, Hemostasis, direct oral anticoagulants

Bio-Engineered Molecule Shows Promise for Quick Control of Bleeding

CamireRodney.jpg

Hematology researchers have developed a novel genetically engineered clotting factor that can control bleeding in animal models. If the factor proves effective and safe in humans, it may provide a quick-acting countermeasure for surgery patients and others vulnerable to serious bleeding as a result of new blood-thinning drugs.







Chat now!